Laddar...
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
Resistance to tamoxifen is a clinically major challenge in breast cancer treatment. Although downregulation of estrogen receptor‐alpha (ERα) is the dominant mechanism of tamoxifen resistance, the reason for ERα decrease during tamoxifen therapy remains elusive. Herein, we reported that Spalt‐like tr...
Sparad:
| I publikationen: | EMBO Mol Med |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6895605/ https://ncbi.nlm.nih.gov/pubmed/31657150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201910638 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|